These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 18953440

  • 1. PI3K/Akt pathway activation attenuates the cytotoxic effect of methyl jasmonate toward sarcoma cells.
    Elia U, Flescher E.
    Neoplasia; 2008 Nov; 10(11):1303-13. PubMed ID: 18953440
    [Abstract] [Full Text] [Related]

  • 2. Cooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-D-glucose.
    Heyfets A, Flescher E.
    Cancer Lett; 2007 Jun 08; 250(2):300-10. PubMed ID: 17125916
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Methyl jasmonate: a plant stress hormone as an anti-cancer drug.
    Cohen S, Flescher E.
    Phytochemistry; 2009 Sep 08; 70(13-14):1600-9. PubMed ID: 19660769
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis of novel methyl jasmonate derivatives and evaluation of their biological activity in various cancer cell lines.
    Sucu BO, Ipek OS, Kurtulus SO, Yazici BE, Karakas N, Guzel M.
    Bioorg Chem; 2019 Oct 08; 91():103146. PubMed ID: 31377389
    [Abstract] [Full Text] [Related]

  • 12. Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells.
    Fingrut O, Reischer D, Rotem R, Goldin N, Altboum I, Zan-Bar I, Flescher E.
    Br J Pharmacol; 2005 Nov 08; 146(6):800-8. PubMed ID: 16170329
    [Abstract] [Full Text] [Related]

  • 13. Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin.
    Yeruva L, Hall C, Elegbede JA, Carper SW.
    Anticancer Drugs; 2010 Jan 08; 21(1):1-9. PubMed ID: 19820395
    [Abstract] [Full Text] [Related]

  • 14. Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway.
    Surmeli Z, Gursoy P, Erdogan AP, Bozkurt E, Atmaca H, Uzunoglu S, Sezgin C, Şanlı UA, Uslu R, Karaca B.
    Tumour Biol; 2016 Mar 08; 37(3):3665-73. PubMed ID: 26462835
    [Abstract] [Full Text] [Related]

  • 15. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y, Chen X, Luo Z.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun 08; 30(6):592-6. PubMed ID: 24909280
    [Abstract] [Full Text] [Related]

  • 16. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
    Wang H, Zhao L, Zhu LT, Wang Y, Pan D, Yao J, You QD, Guo QL.
    Mol Carcinog; 2014 Feb 08; 53 Suppl 1():E107-18. PubMed ID: 23761018
    [Abstract] [Full Text] [Related]

  • 17. Association between reversal of multidrug resistance by methyl jasmonate and P-glycoprotein ATPase activity in hepatocellular carcinoma.
    Wang CF, Wang YQ, Huang FZ, Nie WP, Liu XY, Jiang XZ.
    J Int Med Res; 2013 Aug 08; 41(4):964-74. PubMed ID: 23867448
    [Abstract] [Full Text] [Related]

  • 18. 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer.
    Lin HL, Yang MH, Wu CW, Chen PM, Yang YP, Chu YR, Kao CL, Ku HH, Lo JF, Liou JP, Chi CW, Chiou SH.
    Int J Cancer; 2007 Dec 01; 121(11):2547-55. PubMed ID: 17680560
    [Abstract] [Full Text] [Related]

  • 19. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death.
    Yu HG, Ai YW, Yu LL, Zhou XD, Liu J, Li JH, Xu XM, Liu S, Chen J, Liu F, Qi YL, Deng Q, Cao J, Liu SQ, Luo HS, Yu JP.
    Int J Cancer; 2008 Jan 15; 122(2):433-43. PubMed ID: 17935137
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
    Tsurutani J, West KA, Sayyah J, Gills JJ, Dennis PA.
    Cancer Res; 2005 Sep 15; 65(18):8423-32. PubMed ID: 16166321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.